Rchr
J-GLOBAL ID:201901011512287104   Update date: Nov. 24, 2024

Tamura Shinobu

タムラ シノブ | Tamura Shinobu
Affiliation and department:
Research field  (2): Infectious disease ,  Hematology and oncology
Research theme for competitive and other funds  (3):
  • 2023 - 2026 Unraveling the pathogenesis of inflammatory bowel disorders based on impaired gene rearrangement
  • 2020 - 2023 Pathological characterization of inflammatory bowel disease based on primary immunodeficiency
  • 2005 - 2006 炎症性サイトカインによる痛覚異常の発生機構
Papers (147):
  • Masaki Ibe, Shinobu Tamura, Hideki Kosako, Yusuke Yamashita, Masamichi Ishii, Masaoh Tanaka, Hiroyuki Mishima, Akira Kinoshita, Sadahiro Iwabuchi, Shuhei Morita, et al. Familial schwannomatosis carrying LZTR1 variant p.R340X with brain tumor: A case report. Molecular genetics and metabolism reports. 2024. 40. 101107-101107
  • Takeshi Hirose, Mamoru Ito, Kenji Tsuchihashi, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, et al. Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024. 29. 8. 1067-1073
  • Kazuki Nozawa, Yukinori Ozaki, Tetsuhiro Yoshinami, Takamichi Yokoe, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, et al. Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022. International journal of clinical oncology. 2024. 29. 8. 1074-1080
  • Takeshi Hirose, Mamoru Ito, Kenji Tsuchihashi, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, et al. Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024. 29. 8. 1081-1087
  • Yuho Najima, Tomoya Maeda, Yutaro Kamiyama, Shinji Nakao, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miumra, Makoto Endo, et al. Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024. 29. 7. 899-910
more...
MISC (7):
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page